Health & pharmaceuticals news

Latest breaking stories, features and analysis

This beaten down Cathie Wood stock is a ‘buy’: DA Davidson
  • DA Davidson says Teladoc stock is a "buy" with upside to $45.
  • The bullish note arrives even after the disappointing Q2 report.
  • The Cathie Wood stock is down 60% versus the start of 2022.
August 12, 2022

Trending news

Market analysis

Moderna is a buy at $128 as it moves to re-establish support and resistance levels
June 16, 2022
What next as Moderna finds support at $130?
May 13, 2022
Hold Cigna stock as it eyes a breakout after boosted outlook
May 7, 2022
Sell CVS Health for a chance to buy at these potential levels
April 30, 2022

More breaking stories